Subscribe free

HPB & Spleen ·

High FDG-Avidity in Pancreatic Cancer: 96.3% Tumors Detected, PET Utility in Initial Staging and Neoadjuvant Therapy Planning

Baseline fdg-pet imaging in treatment naïve pdac patients revealed 96.3% had fdg-avid tumors with median suvmax 6.4. fdg-pet identified suspicious extrapancreatic metastatic lesions in 50% of patients, with pet/mri being superior in detection. Ca19-9 elevation did not affect fdg-pet’s performance, highlighting its utility in initial staging and neoadjuvant therapy planning.

Journal Article by Carlson DM, Abdelrahman AM (…) Truty MJ et 7 al. in J Am Coll Surg

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Surgeons.

read the whole article in J Am Coll Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

All papers in HPB & Spleen →